Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology
Shaham Beg(Cornell University), Juan Miguel Mosquera(NewYork–Presbyterian Hospital), Jyothi Manohar(Cornell University), Kenneth Eng(Cornell University), Michael Sigouros(Cornell University), Rohan Bareja(Cornell University), Jenny Xiang(Cornell University), Bishoy M. Faltas(Cornell University), Kentaro Ohara(Cornell University), Andrea Sboner(Cornell University), Himisha Beltran(Dana-Farber Cancer Institute), Wei Zhang(Cornell University), Brian D. Robinson(Cornell University), Francesca Khani(Cornell University), Olivier Elemento(Cornell University), Wael Al Zoughbi(Medical University of Graz), David Wilkes(Cornell University), Rema Rao(Cleveland Clinic), Sarah Kudman(Cornell University), Troy Kane(Cornell University), David J. Pisapia(NewYork–Presbyterian Hospital), Cora N. Sternberg(Cornell University)
Cited by 18
Related Papers
Integrative Clinical Genomics of Advanced Prostate Cancer
|Cell|2015|3.6k
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma
|New England Journal of Medicine|2017|3.4k
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
|New England Journal of Medicine|2014|3k
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
|Nature Cell Biology|2015|2.7k
Ferroptosis is an autophagic cell death process
|Cell Research|2016|1.9k